Cerus Corporation (CERS) Stock Grade

About Cerus Corporation's fundamentals

Cerus Corporation is a healthcare medical device company with a market capitalization of $493.7 million that has demonstrated solid revenue growth of 14.4% year-over-year. Despite this growth trajectory, the company operates at a net loss with a negative net margin of -7.6%, reflecting the typical cash burn pattern of developing medical device firms. However, the company generated positive free cash flow despite its accounting losses, suggesting operational efficiency in converting revenue to actual cash. The company does not pay a dividend, with capital directed toward operations and growth initiatives.